未登录

J

Jarl Hellman

nu hospital group

H指数:11

被引数:1,222

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Diet and diet-related challenges with specific focus on carbohydrates and carbohydrate counting in adults with type 1 diabetes: a cross-sectional study

IF2.3

2025-11-010

PRE

Setting up mother–infant pair lactation studies with biobanking for research according to regulatory requirements

根据监管要求，建立母婴配对泌乳研究并设立生物银行用于研究。

British Journal of Clinical Pharmacology

IF3

2025-08-150

OAAI

Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials

IF10.2

2024-04-261

OAAI

Associations of bolus insulin injection frequency and smart pen engagement with glycaemic control in people living with type 1 diabetes

DIABETES OBESITY & METABOLISM

IF5.7

2023-11-054

OA

Treatment Satisfaction and Well-Being With CGM in People With T1D: An Analysis Based on the GOLD Randomized Trial

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY

IF3.7

2023-07-271

OAAI

Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With Multiple Daily Insulin Injections: An Analysis Based on the GOLD Randomized Trial (GOLD 8)

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY

IF3.7

2022-06-082

OAAI

The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD-5)

DIABETES OBESITY & METABOLISM

IF5.7

2020-12-109

OAAI

Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI

IF16.6

2020-11-1621

OAAI

Increased Time in Range and Fewer Missed Bolus Injections After Introduction of a Smart Connected Insulin Pen

DIABETES TECHNOLOGY & THERAPEUTICS

IF6.3

2020-10-0176

OAAI

The Association Between HbA1cand Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4)

IF16.6

2020-07-0838

OAAI

Sustained Intensive Treatment and Long-Term Effects on A1C Reduction (SILVER Study) by CGM in Persons with T1D Treated with MDI

IF7.5

2020-06-011

PRE

Increased Time-in-Range (TIR) Observed after Introduction of a Connected Insulin Pen

IF7.5

2019-06-012

PRE

Improved Insulin Adherence after Introduction of a Smart Connected Insulin Pen

IF7.5

2019-06-012

PRE

A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3)

连续血糖监测对每日多次注射胰岛素治疗的1型糖尿病患者夜间低血糖、日间低血糖、血糖变异性和低血糖信心的影响的随机临床试验 (GOLD-3)

DIABETES TECHNOLOGY & THERAPEUTICS

IF6.3

2018-04-0185

OAAI

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections The GOLD Randomized Clinical Trial

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

IF55

2017-01-24525

PREAI